Lunai Bioworks Inc.
517.3M
$10.32M
-0.21
$-10.78
No price alerts set. Add an alert to get notified!
-0.21
-1.76
$-10.78
833.76%
0.00%
0.00%
Compare TSM with similar companies in the sector
| Company | Price | Change % | P/E | Market Cap | D/E |
|---|---|---|---|---|---|
|
ADAP
Adaptimmune Therapeutics plc
|
$0.05 | -3.00% | -0.02 | $12.53M | -0.69 |
|
ANL
Adlai Nortye Ltd.
|
$7.88 | -1.32% | -1.61 | $245.99M | 1.07 |
|
APLM
Apollomics, Inc.
|
$19.52 | 0.05% | -0.69 | $21.54M | -0.17 |
|
BLRX
BioLineRx Ltd.
|
$2.74 | 4.00% | -3.86 | $11.90M | 0.58 |
|
ERNA
Ernexa Therapeutics Inc.
|
$0.29 | -3.97% | -0.16 | $2.28M | 0.20 |
|
GOVX
GeoVax Labs, Inc.
|
$1.67 | -2.34% | -0.05 | $1.69M | 0.00 |
|
ICU
SeaStar Medical Holding Corporation
|
$2.42 | 0.83% | -0.47 | $6.75M | 0.00 |
|
LPCN
Lipocine Inc.
|
$7.83 | 7.34% | -4.43 | $43.17M | 0.00 |
|
MBRX
Moleculin Biotech, Inc.
|
$2.14 | 4.15% | -0.08 | $2.58M | -0.01 |
|
THAR
Tharimmune, Inc.
|
$4.07 | -2.98% | -2.42 | $160.89M | 0.00 |
* Peer stocks are selected based on market capitalization and sector
$7.70
$0.15
$0.00
0.00%
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
